Update: Hikma Launches Clindamycin In US
Hikma Pharmaceuticals released Clindamycin in 5% Dextrose Injection in the US.
Hikma Pharmaceuticals released Clindamycin in 5% Dextrose Injection in the US.
Euro area bank interest rates for July 2024 remained stable for new loans to corporations and decreased slightly for new loans to households…
QIAGEN N.V. launches non-US offering of convertible bonds, not available in certain countries; plans to issue $450 million Bonds due 2031 to institutional…
CA Immo sold a fully leased office building in Vienna, developed by them and currently occupied by various international and local tenants.
AstraZeneca shares advancements in cancer care at WCLC and ESMO 2024.
ING has repurchased 268,026 shares at an average price of €16.21 as part of a €2.5 billion share buyback program.
September 03 2024 06:00:44 UTC– In 2022, expenses for medical practices in Germany increased by 11.0% compared to the previous year, Destatis said…
Ahold Delhaize has repurchased 250,000 common shares for €7.7 million as part of a €1 billion buyback program announced in 2023. In total,…
Stellantis Pro One, the Commercial Vehicles division, is a key participant at the IAA Transportation 2024 in Hanover, showcasing various vehicle models from…
Coca-Cola HBC AG announced that its Chief Executive Officer, Zoran Bogdanovic, sold 15,000 ordinary shares at GBP 28.198948 per share on August 30,…